Apart from tumor-intrinsic cGAS-STING induction that could contribute to a beneficial therapeutic outcome (157, 158), a critical event here is the production and release of cGAS-STING agonists that stimulate immune cells. This evidence concerns the gene CGAS and neoplasm.